» Authors » Rune Byrkjeland

Rune Byrkjeland

Explore the profile of Rune Byrkjeland including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 114
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Enge K, Tveit A, Enger S, Onarheim S, Pripp A, Ronningen P, et al.
Eur Heart J Cardiovasc Pharmacother . 2024 May; 10(6):515-525. PMID: 38702844
Aims: Short-term treatment with calcium channel blockers lowers levels of N-terminal pro B-type natriuretic peptide (NT-proBNP) and reduces rhythm-related symptoms compared to treatment with beta-blockers. The aim of this study...
2.
Zaidi H, Aksnes T, Akra S, Eggesbo H, Byrkjeland R, Seljeflot I, et al.
Front Endocrinol (Lausanne) . 2022 Jul; 13:874977. PMID: 35872989
Introduction: Adipokines are highly active biopeptides involved in glucose metabolism, insulin regulation and the development and progression of obesity and its associated diseases. It includes, among others, adiponectin, visfatin and...
3.
Zaidi H, Byrkjeland R, Njerve I, Akra S, Solheim S, Arnesen H, et al.
Adipocyte . 2021 Nov; 10(1):612-620. PMID: 34779349
Introduction: Adipokines, expressed by adipose tissue (AT), have been associated with metabolic disturbances and coronary artery disease (CAD). The impact of exercise training on the AT in patients suffering from...
4.
Aune S, Byrkjeland R, Solheim S, Arnesen H, Troseid M, Awoyemi A, et al.
Diabetol Metab Syndr . 2021 Apr; 13(1):36. PMID: 33794977
Aim: Gut leakage has been shown to associate with low-grade inflammation and lower cardiorespiratory fitness in diabetic subjects. We aimed to investigate whether gut leakage markers related to cardiorespiratory fitness...
5.
Zaidi H, Byrkjeland R, Njerve I, Akra S, Solheim S, Arnesen H, et al.
Diabetol Metab Syndr . 2020 Jan; 11:109. PMID: 31890043
Background: Investigate effects of long-term exercise on the remodeling markers MMP-9, TIMP-1, EMMPRIN and Galectin-3 in combined type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) patients. Any associations...
6.
Bratseth V, Chiva-Blanch G, Byrkjeland R, Solheim S, Arnesen H, Seljeflot I
Diab Vasc Dis Res . 2019 Apr; 16(5):431-439. PMID: 31023084
Objective: Circulating microvesicles, released from activated/apoptotic cells, are involved in vascular complications and may be looked upon as biomarkers. Albuminuria is characteristic of disease progression in type 2 diabetes mellitus....
7.
Zaidi H, Byrkjeland R, Njerve I, Akra S, Solheim S, Arnesen H, et al.
Diab Vasc Dis Res . 2019 Apr; 16(4):360-368. PMID: 30939905
Background: Adipose tissue produces pro-inflammatory mediators involved in the atherosclerotic process. We investigated whether 12-month exercise training in patients with type 2 diabetes mellitus and coronary artery disease would reduce...
8.
Njerve I, Akra S, Weiss T, Solheim S, Ovstebo R, Aass H, et al.
Mediators Inflamm . 2017 Jun; 2017:5380638. PMID: 28596642
Background: Promising results regarding potential anti-inflammatory and antiatherosclerotic effects of gliptins have been reported. Our aim was to investigate whether saxagliptin treatment modifies expression of inflammatory markers, primarily in peripheral...
9.
Byrkjeland R, Njerve I, Arnesen H, Seljeflot I, Solheim S
Diab Vasc Dis Res . 2017 Jan; 14(2):94-103. PMID: 28111980
Objective: We have previously reported insignificant changes in HbA after exercise in patients with both type 2 diabetes and coronary artery disease. In this study, we investigated the effect of...
10.
Bratseth V, Byrkjeland R, Njerve I, Solheim S, Arnesen H, Seljeflot I
Diab Vasc Dis Res . 2017 Jan; 14(2):144-151. PMID: 28111966
We investigated the effects of 12-month exercise training on hypercoagulability in patients with combined type 2 diabetes mellitus and coronary artery disease. Associations with severity of disease were further explored....